W. Zeng

发表

Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice.

Lillian Maggio-Price, P. Morrissey, J. Viney, 2002, The American journal of pathology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Serum biomarkers in a mouse model of bacterial‐induced inflammatory bowel disease

P. Treuting, H. Bielefeldt-Ohmann, T. Brabb, 2008, Inflammatory bowel diseases.

Development of orally active inhibitors of protein and cellular fucosylation

P. Burke, D. Benjamin, P. Senter, 2013, Proceedings of the National Academy of Sciences.

Lineage Targeted MHC-II Transgenic Mice Demonstrate the Role of Dendritic Cells in Bacterial-driven Colitis

C. Ware, R. Hershberg, H. Bielefeldt-Ohmann, 2013, Inflammatory bowel diseases.

A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technology.

P. Burke, P. Senter, D. Sussman, 2013, Bioconjugate chemistry.

Targeted Delivery of Cytotoxic NAMPT Inhibitors Using Antibody–Drug Conjugates

J. Nix, A. Waight, P. Senter, 2018, Molecular Cancer Therapeutics.

Blocking of CD27-CD70 Pathway by Anti-CD70 Antibody Ameliorates Joint Disease in Murine Collagen-Induced Arthritis

H. Gerber, S. Duniho, C. Law, 2009, The Journal of Immunology.

Disease in Murine Collagen-Induced Arthritis Anti-CD70 Antibody Ameliorates Joint Blocking of CD27-CD70 Pathway by

H. Gerber, S. Duniho, C. Law, 2009 .

Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia

John F. Valliere-Douglass, T. Lewis, Sa A. Wang, 2017, Molecular Cancer Therapeutics.

Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice.

R. Hershberg, T. Brabb, J. Viney, 2001, American journal of physiology. Gastrointestinal and liver physiology.

Helicobacter -induced inﬂammatory bowel disease in IL-10- and T cell-deﬁcient mice

R. Hershberg, T. Brabb, J. Viney, 2001 .

5-Azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia

N. Van Rooijen, Martha E. Anderson, C. Law, 2010, mAbs.

Bacterial infection of Smad3/Rag2 double-null mice with transforming growth factor-beta dysregulation as a model for studying inflammation-associated colon cancer.

P. Treuting, B. Iritani, H. Bielefeldt-Ohmann, 2009, The American journal of pathology.

Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice.

P. Treuting, B. Iritani, H. Bielefeldt-Ohmann, 2006, Cancer research.

ITGB1 Drives Hepatocellular Carcinoma Progression by Modulating Cell Cycle Process Through PXN/YWHAZ/AKT Pathways

Yuyou Duan, W. Gu, Qicong Chen, 2021, Frontiers in Cell and Developmental Biology.

SGN-CD123A, a Pyrrolobenzodiazepine Dimer Linked Anti-CD123 Antibody Drug Conjugate, Demonstrates Effective Anti-Leukemic Activity in Multiple Preclinical Models of AML

John F. Valliere-Douglass, R. Walter, D. Benjamin, 2015 .

SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML.

I. Bernstein, P. Burke, R. Walter, 2013, Blood.

Retinoic Acid Receptor β2 Inhibition of Metastasis in Mouse Mammary Gland Xenografts

M. Emond, V. Seewaldt, P. Treuting, 2002, Breast Cancer Research and Treatment.

A coiled-coil masking domain for selective activation of therapeutic antibodies

Matthew R. Levengood, Vivian H. Trang, P. Senter, 2019, Nature Biotechnology.

Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Mark Tsang, Lillian Maggio-Price, P. Morrissey, 2005, The American journal of pathology.

A coiled-coil masking domain for selective activation of therapeutic antibodies

Matthew R. Levengood, Vivian H. Trang, P. Senter, 2019, Nature Biotechnology.

SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML

I. Bernstein, P. Burke, R. Walter, 2012 .

Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma

Hao Wu, B. Su, Tong Zhang, 2019, The Journal of international medical research.

Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice.

Chawnshang Chang, S. Altuwaijri, Kuang-Hsiang Chuang, 2012, The American journal of pathology.

Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis

D. Camidge, L. Chow, H. Burris, 2018, Clinical research.

Mining database for the expression and gene regulation network of JAK2 in skin cutaneous melanoma.

Jiasheng Chen, Wancong Zhang, Xiaoping Zhong, 2020, Life sciences.

Potential Application of MicroRNA Profiling to the Diagnosis and Prognosis of HIV-1 Infection

S. Lian, Haoquan Wu, Hao Wu, 2018, Front. Microbiol..

A LCMS-based untargeted lipidomics analysis of cleft palate in mouse

Jiasheng Chen, Wancong Zhang, Xiaoping Zhong, 2020, Mechanisms of Development.

250 SEA-TGT is a nonfucosylated antibody with distinct and amplified effector function activity that leverages the dependencies of anti-TIGIT anti-tumor activity upon Fc? R engagement

R. Thurman, W. Zeng, S. Gardai, 2020, Journal for ImmunoTherapy of Cancer.

Development of Novel Quaternary Ammonium Linkers for Antibody–Drug Conjugates

Kim K. Emmerton, A. Waight, P. Burke, 2016, Molecular Cancer Therapeutics.